CDER Enforcement Priorities Include Quality Control, Drug "Criminalization"
This article was originally published in The Tan Sheet
Executive Summary
FDA's Center for Drug Evaluation and Research will crack down on manufacturers that attempt to "farm out responsibility," firms that fail to meet reporting requirements and the general "criminalization of our drug supply," said Deb Autor, director of the center's compliance office